IL34 and cancer: In patients with large B-cell lymphoma, IL-34 recruits monocytes, resulting in an increased macrophage ratio in the tissues and a poor prognosis (13) In the context of treatment failure, evidence that the TME plays a critical role in progression, metastasis, and therapeutic resistance via its interactions with cancer cells is increasing (11, 14).